Abstract #4184

Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma

Francesca Branzoli^1,2, Anna Luisa Di Stefano^2,3,4, Malgorzata Marjanska⁵, Romain Valabregue^1,2, Stephane Lehericy^1,2, and Marc Sanson^2,3

¹Brain and Spine Institute (ICM), Center for Neuroimaging Research (CENIR), F-75013, Paris, France, ²INSERM U1127/CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, ICM, F-75013, Paris, France, ³AP-HP, GH Pitié-Salpêtrière, Service de Neurologie 2, F-75013, Paris, France, ⁴Division of Neurology, Foch Hospital, Paris, France, ⁵Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota, Minneapolis, MN, United States

Reliable quantification by magnetic resonance spectroscopy of the oncometabolite 2-hydroxyglutarate (2HG) has important implications in diagnosis of IDH mutation, prognosis, as well as assessment of the efficacy of anti-IDH targeted therapies. In this study, we employed two approaches for 2HG detection previously described, e.g., difference spectroscopy and optimized for 2HG detection conventional spectroscopy, in order to assess for the first time the specificity and sensitivity of the two methods, and to relate these results to the natural history and the neuroradiological status of patients with glioma.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.